Latest filing published 17 Aug 2026 for BridgeBio Pharma, Inc., €1.5M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Randal Scott: trading record in brief
Randal Scott discloses dealings in BridgeBio Pharma, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 24 June 2026 to 17 August 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 17 August 2026, reports a transaction of €1.5M in BridgeBio Pharma, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Randal Scott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 21,501 shares@ US$79.86CommonSEC144:0001950047-26-008246
- 2,196 shares@ US$68.630.0009% mcap100.0% of flowCommonSEC144:0001950047-26-006457
2 of 2 declarations
